CGH

Worldwide Market for Life Science Instrumentation to 2026: Market Opportunities, Expected Growth and Important Trends - ResearchAndMarkets.com

Retrieved on: 
Friday, January 20, 2023
Health, Other Health, Comparative genomic hybridization, Analytic, Cell, Flow cytometry, HCS, Biologically based mental illness, Molecular biology, DNA, Peptide, Synthesizer, NGS, PCR, Biochemistry, SPR, Protein, RNA, Growth, Therapy, Oligonucleotide, Gene expression, Drug discovery, Animal, Laboratory, Global Assessment Report on Biodiversity and Ecosystem Services, Disease, Polymerase chain reaction, Electrophoresis, Global Assessment of Functioning, Electrophysiology, Metagenomics, CGH, Research, Medical device, Fine chemical, Vaccine, Microscope, Medical imaging

The "The Worldwide Market for Life Science Instrumentation, 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Worldwide Market for Life Science Instrumentation, 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The Worldwide Market for Life Science Instrumentation, 2021- 2026 is designed to provide total market knowledge for every significant life science instrumentation category.
  • This comprehensive report details the market opportunity expected growth and important trends in these essential instruments for manufacturing, control, research and development of biopharmaceutical therapies, as well as instruments used for basic life science research.
  • This section is directly extracted from the Global Assessment Report: The Analytical and Life Science Instrumentation Industry.

MicroCloud Hologram（NASDAQ：HOLO）Develops Multiple Algorithms for CGH Technology to Generate 3D Holographic Digital Content

Retrieved on: 
Wednesday, January 18, 2023
Algorithm, Education, Computer graphics, CGH, 3D, Rotation, Research, Table, Computer data storage

BEIJING, Jan. 18, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced that it develops multiple algorithms for generating 3D holographic digital content based on computer imaging technology.

Key Points: 
  • BEIJING, Jan. 18, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced that it develops multiple algorithms for generating 3D holographic digital content based on computer imaging technology.
  • According to the various technical issues faced by the current CGH technology, especially efficiency, HOLO develops and applies multiple algorithms in CGH technology and optimizes them to improve the efficiency and quality of 3D holographic digital images.
  • In addition, to reduce the internal memory occupation of 3D holographic digital content, the dot matrix-based algorithm can divide the 3D holographic objects into multiple 2D slice planes along the axial direction.
  • HOLO's dot-based algorithm, polygon-based algorithm, and layered-based algorithm can be applied to different 3D holographic digital content or the same 3D holographic digital content production according to the varying needs of customers and scenes.

MicroCloud Hologram Develops An SLM-Based Time Division Multiplexing CDHD System

Retrieved on: 
Tuesday, January 17, 2023
Education, CDHD, 2D, Laser, Spatial light modulator, 3D, RGB, Research, Time-division multiplexing, SLM, Medicine, Human, Computer-generated holography, Eye, Security printing, Television, CGH

BEIJING, Jan. 17, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced that it develops an SLM (Spatial Light Modulator)-Based Time Division Multiplexing CDHD (Computer Digital Holographic Display) System.

Key Points: 
  • BEIJING, Jan. 17, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced that it develops an SLM (Spatial Light Modulator)-Based Time Division Multiplexing CDHD (Computer Digital Holographic Display) System.
  • New light modulators, digital sensing sensors, and liquid crystal display technologies are also applied to CDHD technology.
  • HOLO's CDHD system will generate and reconstruct holographic digital images of RGB-colored objects separately based on the SLM-based time-division multiplexing technology.
  • Since HOLO's CDHD system applies SLM-based time difference multiplexing technology, it requires the RGB laser and the corresponding holographic digital content to match sufficiently high frequency (no less than 180Hz).

Caledonia Mining Corporation Plc: Appointment of Gordon Wylie as a non-executive director

Retrieved on: 
Thursday, May 5, 2022
Board, Lydian International, Mining, University, AIM, University of the Witwatersrand, GLOBE, Company, NYSE, CGH, AngloGold Ashanti, Industry, Compliance, Economics, Mineral, Postgraduate diploma, Management, Geology

ST HELIER, Jersey, May 05, 2022 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company")(NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces that Gordon Wylie has joined the board of directors of the Company as an independent non-executive director with immediate effect.

Key Points: 
  • ST HELIER, Jersey, May 05, 2022 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company")(NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces that Gordon Wylie has joined the board of directors of the Company as an independent non-executive director with immediate effect.
  • He has over 46 years experience in the mining industry in both mining and exploration geology.
  • Commenting on Mr Wylie's appointment, Mr Leigh Wilson, Caledonia's Chairman, said:
    "I am delighted to welcome Gordon Wylie to Caledonia's Board.
  • Commenting on his appointment as an independent non-executive director of Caledonia, Mr Wylie said:
    "I am delighted to join Caledonia's Board at this exciting time in the Company's development.

Northwell Health Deploys Telemedicine to Ukraine’s Eastern Front

Retrieved on: 
Wednesday, April 27, 2022
Technology, Medical Supplies, Telecommunications, Philanthropy, Other Health, Health, General Health, Other Philanthropy, Foundation, Transfer, CEO, Government, Medicine, COVID-19, Tablet, Twitter, Medical research, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, MD, Center, Trauma, Hospital, Education, Patient, Telehealth, LinkedIn, Médecins Sans Frontières, Global Health, Feinstein Institute for Medical Research, Instagram, Coronavirus, Multimedia, Physician, Nursing, COVID, Ohio State University Health Sciences Center for Global Health, Health, Emergency medicine, CGH, Health insurance, Northwell Health, Facebook

As Russian forces engage in a second offensive on the eastern border of Ukraine, Northwell Health is providing telemedicine support to aid these frontline regions.

Key Points: 
  • As Russian forces engage in a second offensive on the eastern border of Ukraine, Northwell Health is providing telemedicine support to aid these frontline regions.
  • In February, Northwell aligned with Doctors Without Borders , an organization with extensive experience in combat medicine and humanitarian relief across the globe.
  • Northwell Health is New York States largest health care provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 12,000 affiliated physicians.
  • Our 79,000 employees 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners are working to change health care for the better.

Study of More Than 18,000 Patients Finds Exome Sequencing Delivers Higher Diagnostic Rates for Autism Spectrum Disorders

Retrieved on: 
Tuesday, April 26, 2022
American Academy of Neurology, Genetic testing, Fragile X syndrome, FMR1, LLC, CDC, Genetics, Lists of diseases, Autism, Simons Foundation Autism Research Initiative, Research, Genomics, Database, Diagnosis, Data, National, Patient, Cancer, Standard of care, Gene, AAN, CGH, American Academy, Multimedia, SFARI, ASD, GeneDx, Vaccine, Medical imaging

GAITHERSBURG, Md., April 26, 2022 /PRNewswire/ -- GeneDx, LLC, a leader in genomic analysis, today unveiled new data demonstrating positive outcomes of exome analysis for individuals with autism spectrum disorders (ASD), supporting the use of a broader genetic testing approach to diagnose ASD. This retrospective study is one of the few to examine the genetic basis of autism and current guidelines around screening and testing and is among the largest studies of genetic testing in ASD.

Key Points: 
  • Results demonstrate that exome analysis provides higher diagnostic rates of 7.9-21.0% and shorter diagnosis wait times than traditional testing strategies, including Fragile X (FMR1) and array CGH.
  • Importantly, this study revealed a high number of emerging genes not previously connected to autism.
  • This further supports the use of exome analysis for the discovery and understanding of genes associated with ASD.
  • We will work tirelessly to help ensure all patients have access to exome, which is a more definitive tool."

Global In-situ Hybridization Market Research Report 2022: Market to Reach $1.1 Billion by 2026 - Future Prospects Remain Favorable - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 22, 2022
Pharmaceutical, Genetics, Health, Clinical Trials, Cell, ISH, CAGR, In situ hybridization, Population, DNA, Fluorescence, Lists of diseases, Growth, FISH, Research, Fluorescence in situ hybridization, Incidence, Cancer, CGH, Laboratory, Chromogenic in situ hybridization, Hybridisation, Awareness, Oil, Pet, Pharmaceutical industry

In-situ hybridization helps in the precise localization of a specific nucleic acid segment in a histologic specimen.

Key Points: 
  • In-situ hybridization helps in the precise localization of a specific nucleic acid segment in a histologic specimen.
  • This segment currently accounts for a 28.6% share of the global In Situ Hybridization (ISH) market.
  • The market is poised to post healthy growth over the coming years, driven by various favorable factors steering market expansion.
  • Rise in incidence of cancer and the subsequent demand for personalized medicine, is likely to enhance market prospects in a major way.

Global Biochips/Microarray Markets Report 2021: Impact of Next Generation Sequencing on Microarray Markets for Diagnostics & Drug Discovery - Forecasts to 2025 & 2030

Retrieved on: 
Wednesday, December 1, 2021
CGH, ChIP-on-chip, Microfluidics, Table, CNV, Biochip, Diagnosis, Cancer, Gene expression, MicroRNA, DNA, Infection, RNA, DNA methylation, Literature, Company, Nano, Drug discovery, Growth

DUBLIN, Dec. 1, 2021 /PRNewswire/ -- The "Biochips - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 1, 2021 /PRNewswire/ -- The "Biochips - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
  • This report is an analysis of biochip/microarray markets based on technologies and applications.
  • The report starts with a description of technologies as a basis for the estimation of markets.
  • Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA.

Global Biochips/Microarray Markets, Technologies, & Competitive Landscape Analysis & Forecasts, 2021-2025 & 2030 with 2020 as the Base Year - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 30, 2021
Technology, Other Technology, CGH, ChIP-on-chip, Microfluidics, Table, CNV, Biochip, Diagnosis, Cancer, Gene expression, MicroRNA, DNA, Infection, RNA, DNA methylation, Literature, Company, Nano, Drug discovery, Growth

This report is an analysis of biochip/microarray markets based on technologies and applications.

Key Points: 
  • This report is an analysis of biochip/microarray markets based on technologies and applications.
  • The report starts with a description of technologies as a basis for the estimation of markets.
  • Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice variants, and microRNA.
  • The share of microarray technologies in other areas will grow with the maximum growth in RNA splice variants followed by epigenetics.

Global Cytogenetics Markets, Technology, & Competitive Landscape Report 2021 with Profiles of 70 Companies - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 18, 2021
Technology, Biotechnology, Nanotechnology, Health, CGH, Chromosome, Fort Dix, Single-nucleotide polymorphism, Optical flow, Technology, Magnetic resonance imaging, Biomarker, FISH, PCR, Diagnosis, Disease, SWOT, Nanotechnology, Cancer, SPM, AFM, Human, Fluorescence, Therapy, PNA, Genetic variation, Molecular imaging, Lists of diseases, Hybridization probe, DNA, Organic acid, Infection, MRI, Optical mapping, PET, In situ hybridization, Drug discovery, Company, Genetic disorder, Real-time polymerase chain reaction, Comparative genomic hybridization, Pharmaceutical industry, Medical imaging, Microscope

This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease.

Key Points: 
  • This report deals with cytogenetics in a broader sense rather than the classical use mainly to describe the chromosome structure and identify abnormalities related to disease.
  • The scope of cytogenetics includes several technologies besides fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and multicolor FISH.
  • Molecular cytogenetics includes the applications of nanobiotechnology, microarrays, real-time polymerase chain reaction (PCR), in vivo imaging, and single molecule detection.
  • The report includes summary profiles of 70 companies relevant to cytogenetics along with their 80 collaborations.